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background:  Joint ESC/EASD guidelines recommend testing for diabetes (DM) using oral glucose tolerance test (OGTT) in patients with CAD.
methods: SWEETHEART enrolled 2,767 consecutive patients (pts) with STEMI or NSTEMI to identify newly diagnosed DM (new DM) and to document 
outcome. In pts without DM, OGTT was performed at day 4 after the MI. We examined the impact of known and new DM on 3-year-outcome. 
results: OGTT detected 16.0% new DM in STEMI and 17.8% in NSTEMI. Pts with new DM were younger and suffered from less concomitant 
diseases. 3-year-mortality rates were high, both for known and for new DM, without differences between STEMI and NSTEMI.
Conclusion: OGTT after acute MI identified new DM in 16.0% of STEMI and 17.8% of NSTEMI-pts. For known and new DM, 3-year-mortality was 
similar for STEMI and NSTEMI.
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